|Articles|January 15, 2002
- BioPharm International-01-01-2002
- Volume 15
- Issue 1
From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continues
Author(s)S. Anne Montgomery
by S. Anne Montgomery
Advertisement
Articles in this issue
about 24 years ago
Inside Washington: Biotechnology in the Limelight, the Year Aheadabout 24 years ago
Your Vested Interests: The War of the Westabout 24 years ago
Statistics for Laboratory Method Comparison Studiesabout 24 years ago
Liposomes (a Review): Part Two, Drug Delivery Systemsabout 24 years ago
Information Age AuditsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
5
